Selection of an affinity-matured antibody against a defined epitope by phage display of an immune antibody library

被引:5
作者
Kim, Sang Jick [1 ]
Jang, Myeong Hee [1 ]
Ahn, Hyun Joo [1 ]
Kim, Jin Hong [1 ]
Lim, Ji Hye [1 ]
Ryu, Chun Jeih [1 ]
Lin, Nam-Kyu [2 ]
Kim, Keun-Soo [2 ]
Park, Mi-Ju [1 ]
Park, Insoo [1 ]
Hong, Hyo Jeong [1 ]
机构
[1] Korea Res Ins Biosci & Biotechnol, Therapeut Antibody Res Ctr, Taejon 305333, South Korea
[2] Korea Adv Inst Sci & Technol, Aprogen Inc, Taejon 305701, South Korea
关键词
monoclonal antibody; phage display; epitope tag; hepatitis B virus preS1; affinity maturation;
D O I
10.1016/j.jim.2007.10.009
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In a previous study, we generated a murine hepatitis B virus (HBV)-neutralizing monoclonal antibody (mAb), KR127, that binds to an epitope (amino acids 37-45, NSNNPDWDF) of the preS1 antigen. Furthermore, an epitope tag, S1 (NANNPDWDF), was developed for protein tagging. The aim of the present study was to develop a high-affinity antibody to the same preS I epitope. Mice were immunized with the N-terminal domain of human thrombopoietin fused to the S I tag (nTPO-S1), and a phage-displayed chimeric Fab library was constructed and screened by panning against nTPO-S1. A high-affinity antibody (3-34) was selected that binds to the preS1 antigen. The IgG molecules of 3-34 showed approximately nine-fold higher affinity (K-D 1.2 nM) for preS1 compared with KR127 (K-D 10.4 nM), competed with KR127 for binding to the epitope, and bound to HBV particles. This study provides a simple and efficient way to develop a high-affinity antibody to a defined epitope by phage display of an immune antibody library. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:176 / 183
页数:8
相关论文
共 40 条
  • [1] Adams GP, 1998, CANCER RES, V58, P485
  • [2] IN-VITRO EVOLUTION OF A NEUTRALIZING HUMAN-ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO ENHANCE AFFINITY AND BROADEN STRAIN CROSS-REACTIVITY
    BARBAS, CF
    HU, D
    DUNLOP, N
    SAWYER, L
    CABABA, D
    HENDRY, RM
    NARA, PL
    BURTON, DR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 3809 - 3813
  • [3] Selection and analysis of an optimized anti-VEGF antibody: Crystal structure of an affinity-matured Fab in complex with antigen
    Chen, Y
    Wiesmann, C
    Fuh, G
    Li, B
    Christinger, HW
    McKay, P
    de Vos, AM
    Lowman, HB
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1999, 293 (04) : 865 - 881
  • [4] Improved stability and yield of a Fv-toxin fusion protein by computer design and protein engineering of the Fv
    Chowdhury, PS
    Vasmatzis, G
    Lee, B
    Pastan, I
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1998, 281 (05) : 917 - 928
  • [5] N-terminal myristylation of HBV preS1 domain enhances receptor recognition
    De Falco, S
    Ruvo, M
    Verdoliva, A
    Scarallo, A
    Raimondo, D
    Raucci, A
    Fassina, G
    [J]. JOURNAL OF PEPTIDE RESEARCH, 2001, 57 (05): : 390 - 400
  • [6] STIMULATION OF MEGAKARYOCYTOPOIESIS AND THROMBOPOIESIS BY THE C-MPL LIGAND
    DESAUVAGE, FJ
    HASS, PE
    SPENCER, SD
    MALLOY, BE
    GURNEY, AL
    SPENCER, SA
    DARBONNE, WC
    HENZEL, WJ
    WONG, SC
    KUANG, WJ
    OLES, KJ
    HULTGREN, B
    SOLBERG, LA
    GOEDDEL, DV
    EATON, DL
    [J]. NATURE, 1994, 369 (6481) : 533 - 538
  • [7] SELECTION OF PHAGE ANTIBODIES BY BINDING-AFFINITY - MIMICKING AFFINITY MATURATION
    HAWKINS, RE
    RUSSELL, SJ
    WINTER, G
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1992, 226 (03) : 889 - 896
  • [8] LARGE SURFACE-PROTEINS OF HEPATITIS-B VIRUS CONTAINING THE PRE-S SEQUENCE
    HEERMANN, KH
    GOLDMANN, U
    SCHWARTZ, W
    SEYFFARTH, T
    BAUMGARTEN, H
    GERLICH, WH
    [J]. JOURNAL OF VIROLOGY, 1984, 52 (02) : 396 - 402
  • [9] In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees
    Hong, HJ
    Ryu, CJ
    Hur, H
    Kim, S
    Oh, HK
    Oh, MS
    Park, SY
    [J]. VIROLOGY, 2004, 318 (01) : 134 - 141
  • [10] A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZ19
    Johnson, S
    Griego, SD
    Pfarr, DS
    Doyle, ML
    Woods, R
    Carlin, D
    Prince, GA
    Koenig, S
    Young, JF
    Dillon, SB
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (01) : 35 - 40